Back
ESC Premium Access

Role of cardiac magnetic resonance in stratifying the prognosis of patients with pulmonary arterial hypertension

Session: Pulmonary circulation, pulmonary embolism, right heart failure e-posters
Topic: Pulmonary Hypertension
Speaker: Doctor A. De Lorenzis (Bologna, IT)
Event: ESC Congress 2021 - The Digital Experience

Presentation

0

About the speaker

Doctor Alessandro De Lorenzis

S. Orsola-Malpighi Policlinic, Bologna (Italy)
0 follower

73 more presentations in this session

The novel noninvasive method for prediction of long-term specific therapy efficacy in patients with IPAH and inoperable CTEPH

Speaker: Mrs I. Lyapina (Kemerovo, RU)

Access
Abstract
Slides
1
Thumbnail

Early and long term prognostic accuracy of 4 acute pulmonary embolism mortality risk scores

Speaker: Doctor L. Oliveira (Ponta Delgada, PT)

Access
Abstract
Slides
0
Thumbnail

Novel genetic and molecular pathways in pulmonary arterial hypertension associated with connective tissue disease

Speaker: Doctor I. Hernandez Gonzalez (Valladolid, ES)

Access
Abstract
Slides
0
Thumbnail

Role of echocardiography to avoid misclassification of pulmonary hypertension associated with left heart disease as precapillary pulmonary hypertension.

Speaker: Assistant Professor J. Grignola Rial (Montevideo, UY)

Access
Abstract
Slides
1
Thumbnail

Survival of patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension listed for lung transplantation

Speaker: Doctor I. Magnani (Bologna, IT)

Access
Abstract
0
Thumbnail

Access the full session

Pulmonary circulation, pulmonary embolism, right heart failure e-posters

Speakers: Doctor A. De Lorenzis, Mrs I. Lyapina, Doctor L. Oliveira, Doctor I. Hernandez Gonzalez, Assistant Professor J. Grignola Rial...
Access
1
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

The Future of Cardiology - Panel.

27 August 2021

ESC Premium Access

Real-world, very long-term follow up survival of incident patients with pulmonary hypertension

27 August 2021

ESC Premium Access

Changes in cMRI parameters following a switch to riociguat from phosphodiesterase type 5 inhibitors (PDE5i) in patients with pulmonary arterial hypertension: a REPLACE substudy

27 August 2021

This platform is supported by

logo Novo Nordisk